Globally, breast cancer is one of the most commonly diagnosed forms of cancer and is among the leading causes of cancer death in women. Since the last decade, high prevalence of breast cancer has been observed worldwide and the morbidity rate is rapidly growing. The global female population with age more than 40 years and those on hormone replacement therapy (HRT) are at a higher risk of breast cancer, and thus, aging of population is one of the major factors that has increased the incidence rate of breast cancer worldwide. 
It has been observed that the morbidity rate of breast cancer is higher in developed countries, whereas high mortality rate is noticed in less-developed nations with low financial resources. According to the International Prevention Research Institute (iPRI) in France, in high income countries, not many women are diagnosed with late stage (stage III or IV) breast cancer. However, in low income countries, majority of the women diagnosed with breast cancer were at the later stage of the disease. Thus, it has been realized by the governments of less-developed countries and international healthcare organizations that intensive efforts need to be taken in order to ensure that women in such countries receive early and better solutions for breast cancer diagnosis. Factors such as increase in population size, large pool of geriatric female population, longer life expectancy, increase in awareness, and introduction of early diagnosis programs by governments and healthcare societies are the major contributors to the improving rate of breast cancer diagnosis.
Though various technologies such as, mammography, breast MRI, breast ultrasound, nuclear imaging and tomosynthesis are available in the market for breast cancer diagnosis, mammography is considered as a standard diagnostic tool. Mammography involves the use of low dose of X-rays to obtain two dimensional images of breast tissues. It has been reported that, each year, approximately 44 million women in the U.S. undergo mammography and out of those, 36% women are referred for a second diagnostic test. Many of such women are referred to ultrasound breast screening. Ultrasound is viewed as a promising method of cancer detection among women with dense breasts.
Breast MRI technique uses magnetic waves to capture breast tissue images, while ultrasound uses sound waves with a frequency higher than the human hearing range. Majority of the breast MRI tools use a contrast agent, gadolinium-DPTA. Today, MRI is used for the detection of a wide variety of breast conditions. Their specificity in tumor detection has led to MRI being one of the leading breast cancer detection tools. Nuclear imaging tools such as positron emission tomography (PET) is used for restaging and evaluation of recurrent breast cancer. A number of PET imaging tools are available in the market and their advanced variants are currently under development to determine their efficacy. Commonly used radioactive tracers in nuclear medicine-based breast imaging solutions includeTechnetium-99m (Tc-99m) sestamibi and Fludeoxyglucose (FDG). 
Geographically, North America dominates the global breast imaging market and is followed by Europe. Highly developed healthcare infrastructure and higher rate of awareness are the major factors that contribute to the growth of breast imaging market in these regions. Asia-Pacific is a lucrative market for breast imaging owing to increased incidence of breast cancer screening, mainly in countries like China and India. Contribution of Asian countries to the breast imaging market is expected to further increase as the medical tourism industry rapidly flourishes in this region. 

Breast Imaging Market: Overview

The global prevalence of breast cancer – identified to be the most common form of cancer among women – has been on the rise, especially among women over the age of 40. While the morbidity rate of this cancer has been rapidly increasing in developed countries, the mortality rate is much higher in developing nations owing to lack of awareness and limited availability of advanced healthcare facilities. This growing incidence of breast cancer has been single-handedly driving the market for breast imaging world over.

The report offers a detailed assessment of the various breast imaging technologies and the trajectory of the market during the forecast period. Categorizing the market on the basis of technology into breast MRI, mammography, nuclear imaging, breast ultrasound, tomosynthesis, and others, the report provides in-depth analysis of the various segments and market size estimations through 2019. The key dynamics and trends have been demonstrated and the factors that influence the present as well as future status of the breast imaging market have been discussed.

Breast Imaging Market: Trends and Opportunities

Registering a double-digit CAGR during the forecast period, the breast imaging market is poised to be valued at just over US$4.0 mn by 2019. This can be attributed to the rising use of breast imaging products for diagnosis and monitoring by healthcare professionals, mainly oncology technicians and radiologists. Growing awareness about the benefits of early detection has increasingly supported the demand for breast imaging systems and devices and this can be attributed to supportive government initiatives and programs. The breast imaging market has, as a result, been witnessing considerable growth.

While stringent regulatory norms ensuring the safety of medical equipment and diagnostic tools have been limiting the steady supply of breast imaging systems, technical development and innovative imaging devices are some of the major opportunities market players can capitalize on.

Breast Imaging Market: Regional Outlook

North America has been presenting a strong demand trend for breast imaging over the past decade, with Europe following suit. This can be attributed to greater acceptance ratio for newer technologies and devices, the presence of advanced and sophisticated healthcare infrastructure, higher availability of treatments and technologies, and high awareness rate regarding breast cancer. The Centers for Disease Control and Prevention found that in 2010 alone, nearly 207,000 women and over 2,000 men were diagnosed with breast cancer in the U.S. The World Cancer Research Fund International pegged North America to have the highest number of new breast cancer cases the same year. This increased prevalence of breast cancer drives the North America breast imaging market.

Asia Pacific has been identified as an immensely lucrative region in terms of breast imaging and is primarily driven by growing medical tourism in countries such as China and India. The RoW segment, which comprises the regions of Latin America, the Middle East, and Africa, is anticipated to witness limited growth despite rising government initiatives. This is owing to the fact that awareness levels in these regions is rather low.

Companies mentioned in the report

Some of the leading companies in the highly fragmented breast imaging market are SonoCine Inc., GE Healthcare Ltd., Dilon Technologies, Inc., Aurora Imaging Technologies Inc., Philips Healthcare, Hologic, Inc., Siemens Healthcare Corp., and FUJIFILM SonoSite, Inc. Based on market presence, GE Healthcare, Philips Healthcare, Hologic, and Siemens Healthcare account for the top spots in the global breast imaging market, driven by a wide product portfolio. New product launches, strategic partnerships and agreements, and investments in the development of new imaging systems are some other growth tactics adopted by players in this space.

Major regions analyzed under this research report are:

  • Europe
  • North America
  • Asia Pacific
  • Rest of the World

This report gives you access to decisive data such as:

  • Market growth drivers
  • Factors limiting market growth
  • Current market trends
  • Market structure
  • Market projections for the coming years

Key highlights of this report

  • Overview of key market forces propelling and restraining market growth
  • Up-to-date analyses of market trends and technological improvements
  • Pin-point analyses of market competition dynamics to offer you a competitive edge
  • An analysis of strategies of major competitors
  • An array of graphics and SWOT analysis of major industry segments
  • Detailed analyses of industry trends
  • A well-defined technological growth map with an impact-analysis
  • Offers a clear understanding of the competitive landscape and key product segments